Dextromethorphan found to have potential in treating lung fibrosis - News-Medical

Dextromethorphan, an FDA-approved drug commonly used in cough medicine, shows potential in treating lung fibrosis by impeding collagen that forms scars. A study published in Science Translational Medicine by EMBL Heidelberg scientists revealed its efficacy in reducing lung fibrosis in mouse models and human lung tissue. The research aims to identify the drug's targets in cells to develop improved variants.